BioSpace News Archive

Herbalmax announces Reinvigorator Basic, as part of their expanded product-range of Nicotinamide Mononucleotide (NMN) -based nutraceuticals, enhanced with herbal compounds for metabolic optimization and healthy aging.

Lena Winstedt, PhD, Head of Science at Hansa Biopharma, will present results from a pooled analysis of Phase 2 trials with imlifidase for desensitization in sensitized kidney transplant patients

The global smart pills market size is poised to reach USD 212.97 million by 2023, according to a new report by Technavio, progressing at a CAGR of over 10% during the forecast period.

Constellation Alpha Capital Corp. and DermTech Operations, Inc. announced that they have completed their previously announced business combination.

Allergan plc announced that the Company and its U.S. subsidiaries have reached a settlement with plaintiffs scheduled for trial in October 2019 in the federal opioid multidistrict litigation.

Tolk Chiropractic & Wellness launches Tolk Rewards, a digital rewards program that gives back to loyal patients

Prostate cancer is the second most common cancer for men, both in the United States and worldwide.

Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) www.libertyhealthsciences.com (“Liberty” or the “Company”), a provider of high quality cannabis, announced today that it will open its 17th dispensary in Panama City, Florida on September 3, 2019, subject to approval from the Florida Department of Health.

Seqirus, a global leader in influenza prevention, today presented data at the Options for the Control of Influenza (OPTIONS X) Conference in Singapore from clinical studies demonstrating the ability of a MF59® adjuvanted influenza vaccine to increase immune responses when used in both seasonal and pandemic influenza vaccines, across pediatric and adult populations

Fresenius Kabi announced today the immediate availability in the United States of Phenylephrine Hydrochloride Injection, USP.